rs554062977
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP3BS2
The NM_006514.4(SCN10A):c.599C>T(p.Ala200Val) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000193 in 1,613,778 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006514.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- sodium channelopathy-related small fiber neuropathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- episodic pain syndrome, familial, 2Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
- Brugada syndromeInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN10A | ENST00000449082.3 | c.599C>T | p.Ala200Val | missense_variant, splice_region_variant | Exon 5 of 28 | 1 | NM_006514.4 | ENSP00000390600.2 | ||
| SCN10A | ENST00000643924.1 | c.599C>T | p.Ala200Val | missense_variant, splice_region_variant | Exon 4 of 27 | ENSP00000495595.1 | ||||
| SCN10A | ENST00000655275.1 | c.599C>T | p.Ala200Val | missense_variant, splice_region_variant | Exon 5 of 28 | ENSP00000499510.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152108Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000119 AC: 30AN: 251336 AF XY: 0.000147 show subpopulations
GnomAD4 exome AF: 0.000202 AC: 295AN: 1461552Hom.: 1 Cov.: 31 AF XY: 0.000199 AC XY: 145AN XY: 727060 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000112 AC: 17AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74428 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3
SCN10A: PS3:Supporting -
BS2, PP3 -
Reported in a patient with the type 1 Brugada pattern on ECG; however, it did not segregate with two other relatives who also had the same ECG findings (PMID: 25691538); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30662450, 30821013, 25691538) -
Brugada syndrome 1 Uncertain:1
- -
Brugada syndrome Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 200 of the SCN10A protein (p.Ala200Val). This variant is present in population databases (rs554062977, gnomAD 0.01%). This missense change has been observed in individual(s) with Brugada syndrome and sudden death, in which it was not described to segregate with disease, as well as in two healthy control subjects (PMID: 25691538). ClinVar contains an entry for this variant (Variation ID: 565891). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SCN10A function (PMID: 25691538). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at